The Discounted Cash Flow (DCF) valuation of Moderna Inc (MRNA) is (205.26) USD. With the latest stock price at 145.62 USD, the upside of Moderna Inc based on DCF is -241.0%.
Based on the latest price of 145.62 USD and our DCF valuation, Moderna Inc (MRNA) is a sell. selling MRNA stocks now will result in a potential gain of 241.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.4% - 8.2% | 7.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (464.95) - (134.40) | (205.26) |
| Upside | -419.3% - -192.3% | -241.0% |